Literature DB >> 28986865

NMDA Receptors in the Central Nervous System.

Kasper B Hansen1,2, Feng Yi3, Riley E Perszyk4, Frank S Menniti5, Stephen F Traynelis4.   

Abstract

NMDA-type glutamate receptors are ligand-gated ion channels that mediate a major component of excitatory neurotransmission in the central nervous system (CNS). They are widely distributed at all stages of development and are critically involved in normal brain functions, including neuronal development and synaptic plasticity. NMDA receptors are also implicated in the pathophysiology of numerous neurological and psychiatric disorders, such as ischemic stroke, traumatic brain injury, Alzheimer's disease, epilepsy, mood disorders, and schizophrenia. For these reasons, NMDA receptors have been intensively studied in the past several decades to elucidate their physiological roles and to advance them as therapeutic targets. Seven NMDA receptor subunits exist that assemble into a diverse array of tetrameric receptor complexes, which are differently regulated, have distinct regional and developmental expression, and possess a wide range of functional and pharmacological properties. The diversity in subunit composition creates NMDA receptor subtypes with distinct physiological roles across neuronal cell types and brain regions, and enables precise tuning of synaptic transmission. Here, we will review the relationship between NMDA receptor structure and function, the diversity and significance of NMDA receptor subtypes in the CNS, as well as principles and rules by which NMDA receptors operate in the CNS under normal and pathological conditions.

Entities:  

Keywords:  Disease; Ion channel; Ionotropic glutamate receptor; NMDA; Neurotransmitter; Regulation; Structure-function; Synaptic transmission

Mesh:

Substances:

Year:  2017        PMID: 28986865      PMCID: PMC7325486          DOI: 10.1007/978-1-4939-7321-7_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  521 in total

1.  Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability.

Authors:  Keiko Matsuda; Yoshinori Kamiya; Shinji Matsuda; Michisuke Yuzaki
Journal:  Brain Res Mol Brain Res       Date:  2002-04-30

2.  Context-dependent GluN2B-selective inhibitors of NMDA receptor function are neuroprotective with minimal side effects.

Authors:  Hongjie Yuan; Scott J Myers; Gordon Wells; Katherine L Nicholson; Sharon A Swanger; Polina Lyuboslavsky; Yesim A Tahirovic; David S Menaldino; Thota Ganesh; Lawrence J Wilson; Dennis C Liotta; James P Snyder; Stephen F Traynelis
Journal:  Neuron       Date:  2015-02-26       Impact factor: 17.173

3.  NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.

Authors:  Houman Homayoun; Bita Moghaddam
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

Review 4.  Diverse modes of NMDA receptor positive allosteric modulation: Mechanisms and consequences.

Authors:  David H Hackos; Jesse E Hanson
Journal:  Neuropharmacology       Date:  2016-07-30       Impact factor: 5.250

Review 5.  Translational psychiatry--light at the end of the tunnel.

Authors:  Kenneth A Jones; Frank S Menniti; Digavalli V Sivarao
Journal:  Ann N Y Acad Sci       Date:  2015-03-09       Impact factor: 5.691

6.  Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors.

Authors:  Kasper B Hansen; Stephen F Traynelis
Journal:  J Neurosci       Date:  2011-03-09       Impact factor: 6.167

7.  Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.

Authors:  Brian R Cornwell; Giacomo Salvadore; Maura Furey; Craig A Marquardt; Nancy E Brutsche; Christian Grillon; Carlos A Zarate
Journal:  Biol Psychiatry       Date:  2012-04-21       Impact factor: 13.382

Review 8.  Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders.

Authors:  Kenji Hashimoto; Berend Malchow; Peter Falkai; Andrea Schmitt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-03-01       Impact factor: 5.270

9.  Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.

Authors:  F Chaperon; W Müller; Y P Auberson; M D Tricklebank; H C Neijt
Journal:  Behav Pharmacol       Date:  2003-09       Impact factor: 2.293

10.  Fractional calcium currents through recombinant GluR channels of the NMDA, AMPA and kainate receptor subtypes.

Authors:  N Burnashev; Z Zhou; E Neher; B Sakmann
Journal:  J Physiol       Date:  1995-06-01       Impact factor: 5.182

View more
  44 in total

1.  PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits.

Authors:  Feng Yi; Nirvan Rouzbeh; Kasper B Hansen; Yuelian Xu; Christopher M Fanger; Earl Gordon; Kathy Paschetto; Frank S Menniti; Robert A Volkmann
Journal:  Neuropharmacology       Date:  2020-01-25       Impact factor: 5.250

Review 2.  Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse.

Authors:  Joseph T Coyle; W Brad Ruzicka; Darrick T Balu
Journal:  Am J Psychiatry       Date:  2020-12-01       Impact factor: 18.112

3.  Computer Simulations Predict High Structural Heterogeneity of Functional State of NMDA Receptors.

Authors:  Anton V Sinitskiy; Vijay S Pande
Journal:  Biophys J       Date:  2018-06-28       Impact factor: 4.033

4.  Conformational spread and dynamics in allostery of NMDA receptors.

Authors:  Ryan J Durham; Nabina Paudyal; Elisa Carrillo; Nidhi Kaur Bhatia; David M Maclean; Vladimir Berka; Drew M Dolino; Alemayehu A Gorfe; Vasanthi Jayaraman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-03       Impact factor: 11.205

5.  Modulating inhibitory response control through potentiation of GluN2D subunit-containing NMDA receptors.

Authors:  Patrick M Callahan; Alvin V Terry; Frederick R Nelson; Robert A Volkmann; A B Vinod; Mohd Zainuddin; Frank S Menniti
Journal:  Neuropharmacology       Date:  2020-02-11       Impact factor: 5.250

Review 6.  Expanding Role of NMDA Receptor Antagonists in the Management of Pain.

Authors:  Denise Kreutzwiser; Qutaiba A Tawfic
Journal:  CNS Drugs       Date:  2019-04       Impact factor: 5.749

7.  Hodgkin-Huxley-Katz Prize Lecture: Genetic and pharmacological control of glutamate receptor channel through a highly conserved gating motif.

Authors:  Riley E Perszyk; Scott J Myers; Hongjie Yuan; Alasdair J Gibb; Hiro Furukawa; Alexander I Sobolevsky; Stephen F Traynelis
Journal:  J Physiol       Date:  2020-06-15       Impact factor: 5.182

8.  Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors.

Authors:  Feng Yi; Subhrajit Bhattacharya; Charles M Thompson; Stephen F Traynelis; Kasper B Hansen
Journal:  J Physiol       Date:  2019-11-02       Impact factor: 5.182

Review 9.  Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants.

Authors:  Todd D Gould; Carlos A Zarate; Scott M Thompson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-10-08       Impact factor: 13.820

10.  Visualizing pregnenolone sulfate-like modulators of NMDA receptor function reveals intracellular and plasma-membrane localization.

Authors:  Mariangela Chisari; Timothy J Wilding; Samuel Brunwasser; Kathiresan Krishnan; Mingxing Qian; Ann Benz; James E Huettner; Charles F Zorumski; Douglas F Covey; Steven Mennerick
Journal:  Neuropharmacology       Date:  2018-10-15       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.